Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis

Gastroenterol Hepatol. 2023 Oct;46(8):637-644. doi: 10.1016/j.gastrohep.2022.10.002. Epub 2022 Oct 13.
[Article in English, Spanish]

Abstract

Although low-grade dysplasia (LGD) in Barrett's esophagus (BE) is a histopathological diagnosis based on different histological abnormalities, it is still problematic for different reasons. Patients without confirmed diagnosis of LGD undergo unnecessary and intensified follow-up where the risk of progression is low in the majority of cases. In contrast, the presence of confirmed LGD indicates a high risk of progression. In this article we try to address these reasons focusing on re-confirmation of LGD diagnosis, interobserver agreement, and persistent confirmed LGD. The progression risk of LGD to high-grade dysplasia and esophageal adenocarcinoma will also be reviewed.

Keywords: Barrett's esophagus; Displasia de bajo grado; Esófago de Barrett; Low-grade dysplasia; Progression risk; Riesgo de progresión.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / etiology
  • Adenocarcinoma* / pathology
  • Barrett Esophagus* / complications
  • Barrett Esophagus* / diagnosis
  • Barrett Esophagus* / pathology
  • Disease Progression
  • Esophageal Neoplasms* / diagnosis
  • Esophageal Neoplasms* / etiology
  • Esophageal Neoplasms* / pathology
  • Humans
  • Hyperplasia
  • Precancerous Conditions* / pathology